Jasper Health is a NYC-based cancer care navigation and experience platform led by co-founder and CEO Adam Pellegrini. The platform helps members organize cancer care needs, manage the experience, and understand options, combining a member-focused digital experience, access to cancer care coaches, and a personalized recommendation engine. Nearly 12,000 cancer patients and their caregivers have used Jasper since the service launched last year. The company recently partnered with Employer Direct Healthcare to make the digital platform available to EDH’s client base of more than 2 million lives. Jasper will use the new financing to expand its platform to payers, self-insured employers, and health systems, grow its sales and operations teams, and invest in further research. The round brings total funding to approximately $31m. Jasper Health offers an end-to-end care experience combining an easy-to-navigate user interface, AI-driven care navigation, and access to oncology social workers and live video/asynchronous chat with Jasper Care Guides. The platform helps Members manage appointments, report symptoms and side effects, and receive personalized recommendations and curated content tailored to treatment stages. Jasper is being offered as a platform to health plans, employers, and health systems to connect providers to a patient-centric experience and reduce gaps in care, hospital days, and costs. The company plans integrations with services such as transportation, family care, financial assistance, nutritional guidance, mental health support, and ongoing wellness. Jasper was conceived and launched by Redesign Health and is led by CEO and co-founder Adam Pellegrini, with Greg Orr as Chief Commercial & Product Officer. The team includes digital health experts, specialized oncology social workers, and medical advisers focused on improving outcomes and member experience. As part of its launch, Jasper raised seed funding to support expansion of its offering and continued member support.

Total raised

$32M

Funding rounds

2

Latest round

Series A

Latest activity

Feb 2022